Circulating tumor DNA (ctDNA) can be a prognostic biomarker for non-muscle-invasive bladder cancer (NMIBC); however, targeted sequencing has not been performed to detect ctDNA in NMIBC. We applied tar
Human blood contains cell-free DNA (cfDNA), with circulating tumor-derived DNAs (ctDNAs) widely used in cancer diagnosis and treatment. However, it is still difficult to efficiently and accurately ide
Supplemental table 1. Summary of the overlapped region between AVENIO ctDNA expanded kit targeted genomic region and Sec-seq V-tracking system targeted genomic region.
